Cargando…

IL-35 improves T(reg)-mediated immune suppression in atherosclerotic mice

Interleukin (IL)-35 is an anti-inflammatory cytokine that may have a protective role in atherosclerosis (AS). However, the exact role of IL-35 in the disease, and the etiology of AS, remain incompletely understood. The present study aimed to investigate whether exogenous IL-35 was able to attenuate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Linlin, Zhu, Jie, Chen, Yuefeng, Wang, Qinghang, Pan, Ying, Yu, Qianqian, Zhou, Birong, Zhu, Huaqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038850/ https://www.ncbi.nlm.nih.gov/pubmed/27698748 http://dx.doi.org/10.3892/etm.2016.3649

Ejemplares similares

Adaptive plasticity of IL-10(+) and IL-35(+) T(reg) cells cooperatively promotes tumor T cell exhaustion
por: Sawant, Deepali V., et al.
Publicado: (2019)

Fibrinogen facilitates atherosclerotic formation in Sprague-Dawley rats: A rodent model of atherosclerosis
por: ZHOU, BIRONG, et al.
Publicado: (2013)

T cell anergy in perinatal mice is promoted by T reg cells and prevented by IL-33
por: Tuncel, Jonatan, et al.
Publicado: (2019)

Platelet Integrin αIIbβ3 Inhibitor Rescues Progression of Apoptosis in Human Platelets
por: Zhu, Jie, et al.
Publicado: (2016)

Suppressive IL-17A(+)Foxp3(+) and ex-Th17 IL-17A(neg)Foxp3(+) T(reg) cells are a source of tumour-associated T(reg) cells
por: Downs-Canner, Stephanie, et al.
Publicado: (2017)

An intrinsic role of IL-33 in T(reg) cell-mediated tumor immunoevasion
por: Hatzioannou, Aikaterini, et al.
Publicado: (2019)

In vivo sites and cellular mechanisms of T reg cell–mediated suppression
por: Rudensky, Alexander Y., et al.
Publicado: (2006)

Contribution of IL-12/IL-35 Common Subunit p35 to Maintaining the Testicular Immune Privilege
por: Terayama, Hayato, et al.
Publicado: (2014)

ImmReg: the regulon atlas of immune-related pathways across cancer types
por: Jiang, Tiantongfei, et al.
Publicado: (2021)

Mechanisms of T(reg) Suppression: Still a Long Way to Go
por: Vignali, Dario A. A.
Publicado: (2012)

The Role of IL-35 in the Pathophysiological Processes of Liver Disease
por: Hu, Shuang, et al.
Publicado: (2021)

Interleukin 35 Polymorphisms Are Associated with Decreased Risk of Premature Coronary Artery Disease, Metabolic Parameters, and IL-35 Levels: The Genetics of Atherosclerotic Disease (GEA) Study
por: Posadas-Sánchez, Rosalinda, et al.
Publicado: (2017)

Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells
por: Sekiya, Takashi, et al.
Publicado: (2015)

The Modulation of Endoplasmic Reticulum Stress by Chemical Chaperone Upregulates Immune Negative Cytokine IL-35 in Apolipoprotein E-Deficient Mice
por: Wang, Bo, et al.
Publicado: (2014)

Lasting T reg cell–mediated protection
por: Leslie, Mitch
Publicado: (2009)

Elevated IL-35 level and iTr35 subset increase the bacterial burden and lung lesions in Mycobacterium tuberculosis-infected mice
por: Yu, Fangliu, et al.
Publicado: (2022)

The PTEN pathway in T(regs) is a critical driver of the suppressive tumor microenvironment
por: Sharma, Madhav D., et al.
Publicado: (2015)

Bach2 represses effector programmes to stabilize T(reg)-mediated immune homeostasis
por: Roychoudhuri, Rahul, et al.
Publicado: (2013)

IL-18 and IL-35 in the serum of patients with sepsis thrombocytopenia and the clinical significance
por: Zhu, Meirong, et al.
Publicado: (2020)

Synergistic Activations of REG Iα and REG I β Promoters by IL-6 and Glucocorticoids through JAK/STAT Pathway in Human Pancreatic β Cells
por: Yamauchi, Akiyo, et al.
Publicado: (2015)

IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment
por: Liu, Kewei, et al.
Publicado: (2021)

IL‐23R Deficiency Does Not Impact Atherosclerotic Plaque Development in Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2018)

Controversial Canadian regs.
por: Fields, S
Publicado: (2001)

The mark of T reg cells
por: Van Epps, Heather L.
Publicado: (2005)

New target for T regs
por: Van Epps, Heather L.
Publicado: (2005)

CD25-T(reg)-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity
por: Solomon, Isabelle, et al.
Publicado: (2020)

Macrophage metabolic reprogramming and atherosclerotic plaque microenvironment: Fostering each other?
por: Xiao, Qi, et al.
Publicado: (2023)

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial
por: Ferreira, João Pedro, et al.
Publicado: (2020)

Reg Gene Expression in Periosteum after Fracture and Its In Vitro Induction Triggered by IL-6
por: Tohma, Yasuaki, et al.
Publicado: (2017)

The Clinical Significance and Mechanisms of REG4 in Human Cancers
por: Zhang, Junyan, et al.
Publicado: (2021)

Recombinant p35 from Bacteria Can Form Interleukin (IL-)12, but Not IL-35
por: Aparicio-Siegmund, Samadhi, et al.
Publicado: (2014)

IPR{reg} : identificación del paciente en riesgo /
Publicado: (2013)

Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection
por: Spencer, John David, et al.
Publicado: (2015)

UV-induced T(reg) cells
por: Van Epps, Heather L.
Publicado: (2005)

Tailoring T regs for self preservation
por: Leslie, Mitch
Publicado: (2008)

Half-cocked T reg cells
por: Van Epps, Heather L.
Publicado: (2006)

T reg cells get specific
por: Van Epps, Heather L.
Publicado: (2006)

El Reg's LHC visit
Publicado: (2009)

The expanding impact of T-regs in the skin
por: Hajam, Edries Yousaf, et al.
Publicado: (2022)

REG γ knockdown suppresses proliferation by inducing apoptosis and cell cycle arrest in osteosarcoma
por: Yin, Zhiqiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tk2vemkl09420qas4hm7ttejp4